TELA Bio, Inc. (TELA)

5,89 -0,09 (-1,51%) Alla chiusura: 04:00PM EDT

TELA Bio, Inc.

1 Great Valley Parkway
Suite 24
Malvern, PA 19355
United States
484 320 2930
https://www.telabio.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 227

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Antony Koblish	Co-founder, President, CEO & Director	1,03M	N/D	1966
Mr. Roberto E. Cuca J.D.	CFO & COO	674,78k	N/D	1968
Mr. Paul Talmo	Chief Technology Officer	595,67k	N/D	1972
Ms. Megan Smeykal	VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer	N/D	N/D	1976
Mr. D. Taylor Ocasio	General Counsel & Corporate Secretary	N/D	N/D	N/D
Ms. Jennifer Lou Armstrong	Senior Vice President of Human Resources	N/D	N/D	1970
Mr. Gregory A. Firestone	Chief Business Officer	N/D	N/D	1959
Mr. Michael Leonard	Senior Vice President of Technical Operations	N/D	N/D	N/D
Mr. Peter C. Murphy	Chief Commercial Officer	542,34k	N/D	1973
Louisa Smith	Investor Relations Contact Officer	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Governance aziendale

L'ISS Governance QualityScore di TELA Bio, Inc. al 1 maggio 2024 è 8. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 5; diritti degli azionisti: 8; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.